Primary resistance to ATP-competitive mTOR inhibitors for the treatment of solid tumors
Gregory S. Ducker(University of Utah)
France Medecine
January 1, 2013
Cited by 0
Related Papers
Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
|Proceedings of the National Academy of Sciences|2013|297
The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile
|Proceedings of the National Academy of Sciences|2011|111